T. Rowe Price Investment Management, Inc. - RELAY THERAPEUTICS INC ownership

RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 161 filers reported holding RELAY THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.30 and the average weighting 0.3%.

Quarter-by-quarter ownership
T. Rowe Price Investment Management, Inc. ownership history of RELAY THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$19,035
-33.0%
2,263,3600.0%0.01%
-31.6%
Q2 2023$28,428
-22.3%
2,263,360
+1.9%
0.02%
-26.9%
Q1 2023$36,590
+22.1%
2,221,580
+10.7%
0.03%
+13.0%
Q4 2022$29,978
-99.9%
2,006,541
+10.8%
0.02%
-28.1%
Q3 2022$40,526,0001,811,6030.03%
Other shareholders
RELAY THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Grace Capital 183,112$5,665,0003.48%
Casdin Capital, LLC 3,668,574$115,670,0002.88%
SB INVESTMENT ADVISERS (UK) LTD 27,904,963$879,843,0002.73%
BVF INC/IL 2,049,113$64,609,0002.52%
Fernwood Investment Management, LLC 185,063$5,835,0002.00%
EcoR1 Capital, LLC 1,385,276$43,678,0001.52%
Boxer Capital, LLC 1,294,132$40,804,0001.42%
Integral Health Asset Management, LLC 140,000$4,414,0001.27%
Alphabet Inc. 1,641,497$51,756,0001.23%
Bellevue Group AG 3,755,962$118,426,0001.20%
View complete list of RELAY THERAPEUTICS INC shareholders